Peter Slover
Fortune : 54 775 $ au 30/06/2026
Fortune : 54 775 $ au 30/06/2026
Mr. Peter T.
Slover, CPA, is a Chief Financial & Accounting Officer at Contineum Therapeutics, Inc. Mr. Slover was previously employed as a Chief Financial & Accounting Officer by Sophiris Bio, Inc., a Vice President-Finance & Operations by Anadys Pharmaceuticals, Inc., and an Auditor by KPMG LLP.
He received his undergraduate degree from Shippensburg University of Pennsylvania.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 3 342 ( 0,01 % ) | 54 775 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Directeur Financier/CFO | 01/09/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| SOPHIRIS BIO | Directeur Financier/CFO | 01/05/2020 |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Directeur Financier/CFO | - |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01/01/2004 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Anadys Pharmaceuticals, Inc.
Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel small molecule medicines | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Shippensburg University of Pennsylvania
Shippensburg University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pipeline Therapeutics, Inc.
Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national